Total Payments
$284,103
2024 Payments
$36,493
Companies
47
Transactions
1,672
Payment Breakdown by Category
Other$150,855 (53.1%)
Food & Beverage$46,830 (16.5%)
Consulting$44,630 (15.7%)
Travel$40,992 (14.4%)
Education$796.28 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $145,180 | 66 | 51.1% |
| Food and Beverage | $46,830 | 1,398 | 16.5% |
| Consulting Fee | $44,630 | 18 | 15.7% |
| Travel and Lodging | $40,992 | 169 | 14.4% |
| Honoraria | $5,675 | 3 | 2.0% |
| Education | $796.28 | 18 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $105,462 | 383 | $0 (2024) |
| GENZYME CORPORATION | $99,190 | 201 | $0 (2024) |
| Amgen Inc. | $25,849 | 207 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $8,740 | 55 | $0 (2024) |
| Gilead Sciences, Inc. | $8,721 | 14 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $6,612 | 13 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $4,226 | 9 | $0 (2019) |
| ABBVIE INC. | $2,472 | 69 | $0 (2024) |
| Janssen Biotech, Inc. | $2,137 | 138 | $0 (2024) |
| UCB, Inc. | $2,125 | 86 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,493 | 217 | GENZYME CORPORATION ($16,108) |
| 2023 | $40,021 | 204 | Amgen Inc. ($13,800) |
| 2022 | $12,554 | 131 | Amgen Inc. ($6,372) |
| 2021 | $12,319 | 131 | GENZYME CORPORATION ($5,711) |
| 2020 | $21,222 | 168 | GENZYME CORPORATION ($6,942) |
| 2019 | $67,706 | 239 | GENZYME CORPORATION ($25,200) |
| 2018 | $56,475 | 343 | GENZYME CORPORATION ($25,614) |
| 2017 | $37,314 | 239 | PFIZER INC. ($18,982) |
All Payment Transactions
1,672 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Bone Health | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $36.30 | General |
| Category: Immunology | ||||||
| 12/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $13.79 | General |
| Category: Immunology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $121.08 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Immunology | ||||||
| 11/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $31.18 | General |
| Category: Immunology | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $139.86 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $75.78 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Inflammation | ||||||
| 10/11/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.63 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 09/27/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Not Applicable | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Inflammation | ||||||
About Dr. Ekaterini Zapantis, MD
Dr. Ekaterini Zapantis, MD is a Rheumatology healthcare provider based in Cheektowaga, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1417249202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ekaterini Zapantis, MD has received a total of $284,103 in payments from pharmaceutical and medical device companies, with $36,493 received in 2024. These payments were reported across 1,672 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($145,180).
Ad
Practice Information
- Specialty Rheumatology
- Location Cheektowaga, NY
- Active Since 05/11/2011
- Last Updated 01/06/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417249202
Products in Payments
- XELJANZ (Drug) $104,677
- KEVZARA (Drug) $52,307
- KEVZARA (Biological) $42,147
- TAVNEOS (Drug) $13,089
- COSENTYX (Biological) $8,436
- Tavneos (Drug) $5,955
- NO PRODUCT DISCUSSED (Drug) $5,659
- Enbrel (Biological) $3,391
- ACTHAR (Biological) $3,105
- Otezla (Drug) $2,924
- Cimzia (Drug) $1,976
- TREMFYA (Drug) $1,501
- OFEV (Drug) $1,458
- RINVOQ (Biological) $1,308
- ORENCIA (Biological) $1,219
- SAPHNELO (Biological) $1,097
- KRYSTEXXA (Biological) $873.75
- Rituxan (Biological) $770.14
- Rasuvo (Drug) $737.13
- BENLYSTA (Biological) $705.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.